A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study Participants With Non-Cystic Fibrosis Bronchiectasis
Clinical trial NCT07720375 · RECRUITING
Trial details
- NCT number
- NCT07720375
- Sponsor
- UCB Biopharma SRL
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-05
- Primary completion
- 2029-02-28
- Enrollment
- 300
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.